Entera Bio (ENTX) Capital Expenditures (2021 - 2025)
Entera Bio (ENTX) recorded quarterly Capital Expenditures of $27000.0 in Q4 2025, down 37.21% on a QoQ basis from $43000.0 in Q3 2025, and up 800.0% year-over-year from $3000.0 in Q4 2024.
Entera Bio (ENTX) Capital Expenditures (2021 - 2025) Analysis & Trends
Entera Bio has disclosed Capital Expenditures across 5 years of filings, most recently posting $27000.0 for Q4 2025.
- Quarterly Capital Expenditures rose 800.0% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $99000.0 (up 800.0% YoY) and the FY2025 annual result came in at $107000.0, up 3466.67% from the prior year.
- Capital Expenditures eased to $27000.0 in Q4 2025, from $43000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $43000.0 in Q3 2025 and troughed at $1000.0 in Q2 2023.
- A 5-year average of $13642.9 and a median of $9000.0 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 94.74% — and 2025, when it surged 800.0%.
- Tracing ENTX's Capital Expenditures over 5 years: stood at $10000.0 in 2021, then plunged by 70.0% to $3000.0 in 2022, then surged by 66.67% to $5000.0 in 2023, then tumbled by 40.0% to $3000.0 in 2024, then jumped by 800.0% to $27000.0 in 2025.
- Business Quant data shows ENTX's Capital Expenditures at $27000.0 in Q4 2025, $43000.0 in Q3 2025, and $29000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Sep 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |